SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-23-012859
Filing Date
2023-02-17
Accepted
2023-02-17 16:06:06
Documents
81
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q1222_inmedpharma.htm   iXBRL 10-Q 779371
2 CERTIFICATION f10q1222ex31-1_inmed.htm EX-31.1 11496
3 CERTIFICATION f10q1222ex31-2_inmed.htm EX-31.2 11475
4 CERTIFICATION f10q1222ex32-1_inmed.htm EX-32.1 3478
5 CERTIFICATION f10q1222ex32-2_inmed.htm EX-32.2 3461
6 GRAPHIC image_001.jpg GRAPHIC 4178
  Complete submission text file 0001213900-23-012859.txt   4577764

Data Files

Seq Description Document Type Size
7 XBRL SCHEMA FILE inm-20221231.xsd EX-101.SCH 73879
8 XBRL CALCULATION FILE inm-20221231_cal.xml EX-101.CAL 31249
9 XBRL DEFINITION FILE inm-20221231_def.xml EX-101.DEF 246349
10 XBRL LABEL FILE inm-20221231_lab.xml EX-101.LAB 478874
11 XBRL PRESENTATION FILE inm-20221231_pre.xml EX-101.PRE 260095
75 EXTRACTED XBRL INSTANCE DOCUMENT f10q1222_inmedpharma_htm.xml XML 453259
Mailing Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4
Business Address SUITE 310, 815 W. HASTINGS STREET VANCOUVER A1 V6C 1B4 (604) 669-7207
InMed Pharmaceuticals Inc. (Filer) CIK: 0001728328 (see all company filings)

IRS No.: 000000000 | State of Incorp.: A1 | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-39685 | Film No.: 23642472
SIC: 2834 Pharmaceutical Preparations